CDA | Evidence Driven
CDA | Evidence Driven

Acamprosate calcium

Details

Files
Generic Name:
Acamprosate calcium
Project Status:
Complete
Therapeutic Area:
Alcohol Abstinence
Manufacturer:
Prempharm Inc.
Brand Name:
Campral
Project Line:
Reimbursement Review
Project Number:
SR0108-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Alcohol Abstinence
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:

Files

Submission Status Report View PDF
Recommendation and Reasons View PDF
Summary of CEDAC Discussion View PDF
Overview of CDR Reports View PDF
Plain Language Recommendation View PDF
Last Updated : August 29, 2007